Jung D, Shin SM, Kim KH, Kim KJ, Park EJ. Botulinum toxin A modulates keratinocyte proliferation and inflammatory and pruritic mediators in wound healing. Ann Dermatol. 2025;37(5):269-275.
Baek EJ, Shin SM, Kim SJ, Kim KH, Kim KJ, Park EJ. Alitretinoin for the treatment of lichen amyloidosis: A retrospective, observational study and an in vitro study. Dermatol Ther. 2025;2025:7835429.
Shin SM, Baek EJ, Kim KH, Kim KJ, Park EJ. Polydeoxyribonucleotide exerts opposing effects on ERK activity in human skin keratinocytes and fibroblasts. Mol Med Rep. 2023;28(2):148.
Shin SM, Baek EJ, Oh DY, Kim KH, Kim KJ, Park EJ. Functional validation of co-culture model of human keratinocytes and neuronal cell line for sensitive skin by using transient receptor potential channel vanilloid subfamily member 1 antagonist. Skin Res Technol. 2023;29.
Park GS, An MK, Yoon JH, Park SS, Koh SH, Mauro TM, Cho EB, Park EJ, Kim KH, Kim KJ. Botulinum toxin type A suppresses pro-fibrotic effects via the JNK signaling pathway in hypertrophic scar fibroblasts. Arch Dermatol Res. 2019;311:807-814.
Cho EB, Park GS, Park SS, Jang YJ, Kim KH, Kim KJ, Park EJ. Effect of platelet-rich plasma on proliferation and migration in human dermal fibroblasts. J Cosmet Dermatol. 2019;18:1105-1112.